How should frequent epistaxis in a 31-year-old woman be evaluated and managed?

Management of Frequent Epistaxis in a 31-Year-Old Woman

Apply firm, continuous pressure to the soft lower third of the nose for a full 10–15 minutes without checking for cessation, and if bleeding persists add topical oxymetazoline or phenylephrine spray—this two-step approach controls 65–75% of cases and should be attempted before any further intervention. 1

Immediate Assessment Priorities

Document critical risk factors that increase bleeding frequency or severity:

• Personal or family history of bleeding disorders (von Willebrand disease, hemophilia, easy bruising, prolonged bleeding from minor cuts) 1
• All anticoagulant and antiplatelet medications (warfarin, aspirin, clopidogrel, direct oral anticoagulants, NSAIDs) 1
• Intranasal drug use (nasal corticosteroids increase epistaxis risk 2.7-fold; cocaine or other illicit inhalants cause severe mucosal injury) 1, 2
• Bilateral recurrent nosebleeds or family history of recurrent nosebleeds (suggests hereditary hemorrhagic telangiectasia) 1
• Environmental factors (dry heat, nasal oxygen, CPAP use) 2

Obtain a baseline blood pressure measurement because approximately 33% of epistaxis patients have undiagnosed hypertension. 1 However, do not acutely lower blood pressure during active bleeding—excessive reduction can cause renal, cerebral, or coronary ischemia. 2

First-Line Treatment Algorithm

Step 1: Compression (10–15 minutes)

• Position the patient seated upright with head tilted slightly forward to prevent blood from entering the airway 1
• Apply firm, sustained pressure to the soft lower third of the nose for a full 10–15 minutes without intermittent checking—premature release is the most common cause of treatment failure 1
• Instruct the patient to breathe through the mouth and spit out blood rather than swallow it 1

Step 2: Add Topical Vasoconstrictor (if bleeding persists)

• Clear blood clots by suction or gentle nose blowing 1
• Apply 2 sprays of oxymetazoline or phenylephrine into the bleeding nostril 1
• Resume firm compression for another 5–10 minutes 1
• This combination stops bleeding in 65–75% of emergency department cases 1

Step 3: Identify the Bleeding Source

• Perform anterior rhinoscopy after clot removal to locate the bleeding site (most commonly Kiesselbach's plexus on the anterior septum) 1, 2
• If the source remains unclear or bleeding is difficult to control, proceed to nasal endoscopy—this localizes the bleeding site in 87–93% of cases 1

Step 4: Cauterization (if a focal bleeding point is identified)

• Anesthetize the site with topical lidocaine or tetracaine 1
• Cauterize only the active bleeding point—electrocautery is more effective than chemical cauterization (14.5% vs. 35.1% recurrence) 1
• Never perform bilateral simultaneous septal cautery—this markedly increases the risk of septal perforation 1

Step 5: Nasal Packing (if bleeding persists after 15–30 minutes of proper compression with vasoconstrictors)

• Use only resorbable/absorbable packing materials (Nasopore, Surgicel, Floseal) in patients on anticoagulants or antiplatelet agents to avoid trauma during removal 1
• Non-resorbable packing may be used in patients without bleeding risk factors 1

Prevention of Recurrence

After achieving hemostasis, implement daily preventive measures:

• Apply petroleum jelly or nasal saline gel to the anterior nasal mucosa 2–3 times daily to maintain moisture 1
• Use saline nasal sprays frequently throughout the day 1
• Place a bedside humidifier in dry environments 1
• Avoid digital trauma (nose picking) and vigorous nose blowing for at least 7–10 days 1

Red Flags Requiring Specialist Referral

Refer to otolaryngology if any of the following are present:

• Recurrent bilateral epistaxis or family history of recurrent nosebleeds (evaluate for hereditary hemorrhagic telangiectasia) 1
• Unilateral epistaxis with nasal obstruction, facial pain, or visual changes (exclude nasal masses, juvenile nasopharyngeal angiofibroma, or malignancy) 2
• Bleeding persists despite appropriate cauterization and packing 1
• Three or more recent episodes despite preventive measures 1
• Bleeding duration exceeds 30 minutes over a 24-hour period 1

Advanced Interventions for Refractory Cases

If nasal packing fails or bleeding recurs, evaluate for:

• Endoscopic sphenopalatine artery ligation (97% success rate) 1
• Endovascular embolization (80% success rate, <10% recurrence vs. 50% for nasal packing) 1

Critical Pitfalls to Avoid

• Do not check for cessation of bleeding before the full 10–15 minutes of compression—premature release is the leading cause of treatment failure 1
• Do not use non-resorbable packing in patients on anticoagulants or antiplatelet agents—this causes significant mucosal trauma during removal 1
• Do not perform bilateral septal cautery—this dramatically increases septal perforation risk 1
• Do not discontinue anticoagulants or antiplatelet agents for non-life-threatening epistaxis—local measures should be attempted first 1
• Do not overlook hereditary hemorrhagic telangiectasia in patients with recurrent bilateral epistaxis—these patients require specialized management at an HHT Center of Excellence 1

Follow-Up

Document outcomes within 30 days after any invasive treatment (packing, cauterization, surgical intervention) to monitor for complications and recurrent bleeding. 1 Adequate follow-up allows assessment for underlying conditions when treatments are ineffective or bleeding recurs. 1